KalVista Pharmaceuticals, Inc. (KALV)
15.80
-0.09
(-0.57%)
USD |
NASDAQ |
Feb 20, 16:00
15.80
0.00 (0.00%)
After-Hours: 19:00
KalVista Pharmaceuticals Market Cap : 798.63M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioCryst Pharmaceuticals, Inc. | 1.847B |
| Iovance Biotherapeutics, Inc. | 1.143B |
| Plus Therapeutics, Inc. | 38.59M |
| BioStem Technologies, Inc. | 101.50M |
| Protokinetix, Inc. | 3.069M |
Market Cap Related Metrics
| PS Ratio | 54.81 |
| PEG Ratio | -0.3849 |
| Price to Book Value | 46.98 |
| Price | 15.80 |
| Earnings Yield | -25.40% |
| PEGY Ratio | -0.3849 |